DE60031422D1 - Peptidanaloge als selektive inhibitoren der thrombinaktivierung des durch protease aktivierten rezeptors - Google Patents

Peptidanaloge als selektive inhibitoren der thrombinaktivierung des durch protease aktivierten rezeptors

Info

Publication number
DE60031422D1
DE60031422D1 DE60031422T DE60031422T DE60031422D1 DE 60031422 D1 DE60031422 D1 DE 60031422D1 DE 60031422 T DE60031422 T DE 60031422T DE 60031422 T DE60031422 T DE 60031422T DE 60031422 D1 DE60031422 D1 DE 60031422D1
Authority
DE
Germany
Prior art keywords
thrombinactivation
protease
activated receptor
selective inhibitors
peptide analogue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60031422T
Other languages
English (en)
Other versions
DE60031422T2 (de
Inventor
H Schmaier
Ahmed A K Hasan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Michigan
Thromgen Inc
Original Assignee
University of Michigan
Thromgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Michigan, Thromgen Inc filed Critical University of Michigan
Publication of DE60031422D1 publication Critical patent/DE60031422D1/de
Application granted granted Critical
Publication of DE60031422T2 publication Critical patent/DE60031422T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DE60031422T 1999-08-17 2000-08-17 Peptidanaloga als selektive Inhibitoren der Thrombinaktivierung des proteaseaktivierten Rezeptors 1 Expired - Fee Related DE60031422T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/375,808 US6544750B1 (en) 1999-08-17 1999-08-17 Peptide analogs as selective inhibitors of thrombin activation of protease activated receptor 1
US375808 1999-08-17
PCT/US2000/040669 WO2001012656A1 (en) 1999-08-17 2000-08-17 Peptide analogs as selective inhibitors of thrombin activation of protease activated receptor 1

Publications (2)

Publication Number Publication Date
DE60031422D1 true DE60031422D1 (de) 2006-11-30
DE60031422T2 DE60031422T2 (de) 2007-08-23

Family

ID=23482441

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60031422T Expired - Fee Related DE60031422T2 (de) 1999-08-17 2000-08-17 Peptidanaloga als selektive Inhibitoren der Thrombinaktivierung des proteaseaktivierten Rezeptors 1

Country Status (9)

Country Link
US (1) US6544750B1 (de)
EP (1) EP1212352B1 (de)
JP (1) JP2003507389A (de)
AT (1) ATE342914T1 (de)
AU (1) AU764707B2 (de)
CA (1) CA2382056A1 (de)
DE (1) DE60031422T2 (de)
IL (1) IL148173A0 (de)
WO (1) WO2001012656A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6346510B1 (en) 1995-10-23 2002-02-12 The Children's Medical Center Corporation Therapeutic antiangiogenic endostatin compositions
US6841354B2 (en) * 2000-12-21 2005-01-11 Philadelphia, Health & Education Corporation Screening assay for anti-thrombotic/anti-platelet activity
US20060142203A1 (en) * 2002-06-26 2006-06-29 Todd Hembrough Compositions and methods comprising protein activated receptor antagonists
US7074765B2 (en) * 2003-05-01 2006-07-11 The Regents Of The University Of Michigan Synthetic peptide analogs of Arg-Pro-Pro-Gly-Phe as selective inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4
AU2005277203A1 (en) * 2004-08-20 2006-03-02 Entremed, Inc. Compositions and methods comprising proteinase activated receptor antagonists
DE602005023429D1 (de) 2004-10-19 2010-10-21 Lonza Ag Verfahren zur festphasen-peptidsynthese
CN103384496B (zh) 2010-12-02 2016-10-12 贝克顿·迪金森公司 含有血液稳定剂的血液收集装置
EP2988130A1 (de) * 2014-08-20 2016-02-24 Eppendorf Ag Verfahren zur Beschichtung eines festen Trägers
US20180214476A1 (en) * 2017-02-01 2018-08-02 North Carolina State University Thrombin-responsive hydrogels and devices for auto-anticoagulant regulation
CN113429459B (zh) * 2021-06-16 2022-07-26 昆明医科大学第一附属医院 一种抗血小板多肽及其药物组合物与其应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0410540A1 (de) * 1989-07-28 1991-01-30 Merck & Co. Inc. Fibrinogenrezeptorantagonisten
JPH05503712A (ja) 1990-10-11 1993-06-17 プロ―ソマ・サルル 診断方法
US5461032A (en) * 1991-03-01 1995-10-24 Fmc Corporation Insecticidally effective peptides
IE20030749A1 (en) 1991-05-03 2003-11-12 Indiana University Foundation Human notch and delta binding domains in torporythmic proteins, and methods based thereon
WO1993003748A1 (en) 1991-08-13 1993-03-04 Temple University - Of The Commonwealth System Of Higher Education Modulation of blood pressure and inhibition of platelet activation with kininogen fragment
US5225531A (en) * 1992-04-09 1993-07-06 Washington University Hexapeptide Lys Gly Ala Gly Asp Val
US5747447A (en) * 1992-04-30 1998-05-05 Cor Therapeutics Stable polypeptide composition
US5589458A (en) 1992-11-13 1996-12-31 Thomas Jefferson University Compounds that inhibit T cell proliferation and methods for using the same
US5631131A (en) 1993-03-19 1997-05-20 Universite De Montreal cDNA probes and antibodies for human methenyltetrahydrofolate synthetase
US5491086A (en) 1993-05-14 1996-02-13 Hoffmann-La Roche Inc. Purified thermostable nucleic acid polymerase and DNA coding sequences from pyrodictium species
US5762939A (en) 1993-09-13 1998-06-09 Mg-Pmc, Llc Method for producing influenza hemagglutinin multivalent vaccines using baculovirus
US6143719A (en) * 1995-06-09 2000-11-07 The Regents Of The University Of Michigan Bradykinin analogs as selective thrombin inhibitors
WO1998047522A1 (en) 1997-04-23 1998-10-29 The Regents Of The University Of Michigan Bradykinin analogs as selective inhibitors of cell activation
AU2662999A (en) 1998-02-09 1999-08-23 Genzyme Corporation Nucleic acid delivery vehicles
US6111075A (en) 1998-04-01 2000-08-29 Zymogenetics, Inc. Protese-activated receptor PAR4 (ZCHEMR2)

Also Published As

Publication number Publication date
WO2001012656A1 (en) 2001-02-22
CA2382056A1 (en) 2001-02-22
JP2003507389A (ja) 2003-02-25
US6544750B1 (en) 2003-04-08
EP1212352A4 (de) 2002-12-04
DE60031422T2 (de) 2007-08-23
EP1212352B1 (de) 2006-10-18
EP1212352A1 (de) 2002-06-12
AU7882200A (en) 2001-03-13
ATE342914T1 (de) 2006-11-15
AU764707B2 (en) 2003-08-28
IL148173A0 (en) 2002-09-12

Similar Documents

Publication Publication Date Title
ATE299493T1 (de) N-cyanomethylamide als protease inhibitoren
ATE549028T1 (de) Stabile analoga von glp-1
ATE481106T1 (de) Heterocyclische sulfonamid-hepatitis-c-virus- hemmer
DE60336550D1 (de) Inhibitoren des hepatitis-c-virus
CO6241137A2 (es) Antagonistas ciclicos de peptido cxcr4
SG159385A1 (en) Inhibitors of serine proteases, particularly hepatitis c virus ns3 - ns4 protease
ATE413411T1 (de) Substituierte cycloalkyl p1' hepatitis c virus inhibitoren
MXPA04003825A (es) Inhibidores de serina proteasa, en particular la ns3-ns4a proteasa del virus de hepatitis c, que incorpora un sistema de anillo fusionado.
HRP20050585A2 (en) Peptides which inhibit angiogenesis, cell migration, cell invasion and cell proliferation, compositions and uses thereof
DE60031422D1 (de) Peptidanaloge als selektive inhibitoren der thrombinaktivierung des durch protease aktivierten rezeptors
ATE435852T1 (de) Gpe-analoga und peptidomimetika
DE50105373D1 (de) Dipeptidische hemmstoffe für den gerinnungsfaktor xa
ATE373636T1 (de) Amidderivate als inhibitoren der enzymatischen aktivität von renin
TR200103240T2 (tr) Endoparazit öldürücü bileşimler.
MXPA04004450A (es) Nuevos compuestos y composiciones como inhibidores de catepsina s.
DE10394174D2 (de) Peptide mit hohem Cysteingehalt
EP1452522A3 (de) Neue Verbindungen und Zusammensetzungen als Protease Inhibitore

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee